Afghanistan vs Turkmenistan: Prevalence rate of diabetes in adults
Afghanistan
11.9
in 2014
Turkmenistan
12.2
in 2014
Afghanistan rank
42nd
Turkmenistan rank
39th
Prevalence rate of diabetes in adults over time
- Afghanistan
- Turkmenistan
How they compare
Turkmenistan currently reports 12.2 against 11.9 in Afghanistan, a difference of 0.3.
The two have swapped places 2 times across 35 shared years of data; in 1980 it was Turkmenistan ahead.
Afghanistan ranks 42nd and Turkmenistan ranks 39th of 190 countries.
Afghanistan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Afghanistan | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 5.62 | 5.24 | 0.38 | Afghanistan |
| 1990s | 7.31 | 6.4 | 0.91 | Afghanistan |
| 2000s | 9.39 | 8.52 | 0.87 | Afghanistan |
| 2010s | 11.34 | 11.26 | 0.08 | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Afghanistan or Turkmenistan?
- Turkmenistan, at 12.2 against 11.9 in Afghanistan as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Afghanistan and Turkmenistan?
- 0.3, with Turkmenistan ahead.
- How many years of comparable data are there for Afghanistan and Turkmenistan?
- 35 years are reported by both, from 1980 to 2014.
- How do Afghanistan and Turkmenistan rank globally for prevalence rate of diabetes in adults?
- Afghanistan ranks 42nd and Turkmenistan ranks 39th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) β with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.